Skip to main content

Advertisement

Table 3 Patients’ perception of HCV-related services in their treatment programs

From: Hepatitis C infection, related services, and barriers to HCV treatment among drug users in methadone maintenance treatment (MMT) clinics in Shanghai, China

  Total (n = 240) HCV positive (n = 168) HCV negative (n = 72)
Need HCV-related training when receiving treatment, mean (SD) 6.0 (3.1) 6.1 (3.2) 5.9 (3.2)
Need HCV testing when receiving treatment, n (%) 199 (82.3) 144 (85.7) 55 (76.4)
Need HCV medical support when receiving treatment, mean (SD) 7.1 (2.9) 7.2 (2.8) 6.7 (3.2)
Barriers preventing patients from using these services
 Worry that others know about the infection, mean (SD) 3.6 (3.6) 3.8 (3.6) 3.1 (3.6)
 Not engaging in risky behavior, will not suffer from HCV, mean (SD) 2.6 (3.3) 2.3 (3.1) 3.4 (3.8)
 No physical discomfort, do not need to treat HCV infection, mean (SD) 3.2 (3.5) 2.8 (3.3) 4.2 (3.7)
 Worry about withdrawal is unsanitary, so do not test, mean (SD) 2.6 (3.1) 2.19 (2.98) 2.73 (3.52)
 Cannot afford treatment, n (%) 184 (77.3) 133 (79.2) 51 (72.3)
 Cannot find HCV treatment sites, n (%) 132 (55.2) 98 (58.3) 34 (47.9)
 Doctors cannot comply with the orders, adhere to long-term treatment, n (%) 111 (46.4) 80 (47.6) 31 (43.7)
 Do not have enough time, n (%) 139 (57.9) 96 (57.1) 43 (59.7)
 Satisfied with HCV testing service, mean (SD) 7.7 (2.7) 7.5 (2.7) 8.1 (2.7)
 Satisfied with HCV education in current treatment site, mean (SD) 7.0 (2.6) 6.9 (2.5) 6.8 (2.9)
 Satisfied with medical support, mean (SD) 7.4 (2.7) 7.2 (2.7) 7.7 (2.6)